Buscar resultados de ensayos clínicos
Li-Fraumeni Syndrome - 25 Studies Found
Estado | Estudiar |
Not yet recruiting |
Nombre del estudio: Recombinant Adenoviral Human p53 Gene in Treatment of Malignant Pleural Effusion Condición: Malignant Pleural Effusion Fecha: 2015-04-24 Intervenciones:
|
Not yet recruiting |
Nombre del estudio: rAd-p53 Gene Therapy for Advanced Malignant Thyroid Tumors Condición: Advanced Malignant Thyroid Tumors Fecha: 2009-05-12 Intervenciones:
|
Not yet recruiting |
Nombre del estudio: The p53 Colorectal Cancer Trial Condición:
|
Not yet recruiting |
Nombre del estudio: p53 Gene Therapy in Treatment of Diabetes Concurrent With Hepatocellular Carcinoma Condición:
Fecha: 2015-09-11 Intervenciones:
|
Not yet recruiting |
Nombre del estudio: P53 Gene Combined With Radio- and Chemo-therapy in Treatment of Unresectable Locally Advanced Head and Neck Cancer Condición: Advanced Head and Neck Cancer Fecha: 2015-04-20 Intervenciones:
|
Recruiting |
Nombre del estudio: Trans-catheter Arterial Embolization Combined With p53 Gene Therapy for Treatment of Advanced Hepatocellular Carcinoma Condición: Advanced Hepatocellular Carcinoma (HCC) Fecha: 2015-07-19 Intervenciones:
|
Recruiting |
Nombre del estudio: Trans-catheter Chemo-embolization Combined With rAd-p53 Gene Injection in Treatment of Advanced Hepatocellular Carcinoma Condición: Advanced Adult Hepatocellular Carcinoma Fecha: 2015-03-25 Intervenciones:
|
Recruiting |
Nombre del estudio: Study to Determine and Evaluate a Safe and Tolerated Dose of HDM201 in Patients With Selected Advanced Tumors That Are TP53wt Condición: Advanced Solid and Hematological TP53wt Tumors Fecha: 2014-05-19 Intervenciones:
|
Not yet recruiting |
Nombre del estudio: p53 Gene in Treatment of Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer Condición:
|
Recruiting |
Nombre del estudio: A Study Evaluating Venetoclax in Subjects With Chronic Lymphocytic Leukemia Whose Cancer Has Come Back or Who Had No Response to Previous Cancer Treatments Including Subjects Missing Part of Their Chromosome 17, or TP53 Gene Mutation; or Who Received Prior Treatment With a B-Cell Receptor Inhibitor Condición: Chronic Lymphocytic Leukemia (CLL) Fecha: 2016-11-30 Intervenciones: Drug: Venetoclax Tablet Other Name: ABT-199 |